Kirsten Maertens
Overview
Explore the profile of Kirsten Maertens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
593
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dierckx L, Rodriguez-Ruiz J, Ekinci E, van Heirstraeten L, Willen L, Cuypers L, et al.
J Clin Microbiol
. 2025 Mar;
:e0169624.
PMID: 40071954
serotype 23B, a non-vaccine serotype, has shown an increasing prevalence and penicillin non-susceptibility among carriage and invasive pneumococcal disease (IPD) isolates. Recently, a novel penicillin non-susceptible genotype has emerged, named...
2.
De Brabandere L, Hanning N, Hendrickx G, Van Damme P, Maertens K
Pediatr Infect Dis J
. 2025 Feb;
44(2S):S141-S145.
PMID: 39951092
Background: There is a wide variety of vaccination programs during pregnancy implemented in different European Union (EU) countries. The recent coronavirus disease 2019 (COVID-19) pandemic emphasized the need for efficient...
3.
Jennen L, De Weerdt L, Kouriannidi E, Hanning N, Toledo Cornejo A, Willen L, et al.
Pediatr Infect Dis J
. 2025 Feb;
44(2S):S61-S65.
PMID: 39951077
Background: Cell-mediated immunity (CMI), in addition to the humoral immune response, is crucial in clearing infections. Cytokines are important mediators of the immune system and play a role during pregnancy...
4.
Munoz F, Avila Aguero M, Cutland C, Dinleyici E, Eckert L, Giles M, et al.
Pediatr Infect Dis J
. 2025 Feb;
44(2S):S2-S8.
PMID: 39951063
No abstract available.
5.
De Weerdt L, Herzog S, Van Damme P, Maertens K
Vaccine
. 2024 Aug;
42(21):126152.
PMID: 39088988
Background: Pertussis vaccination in pregnancy has been introduced in an increasing number of countries to better protect infants against the disease in their first weeks of life. The optimal timing...
6.
De Weerdt L, Thiriard A, Leuridan E, Marchant A, Maertens K
Front Immunol
. 2024 Mar;
15:1360201.
PMID: 38464513
Background: Tetanus, diphtheria, acellular pertussis (Tdap) vaccination is recommended to be administered in every pregnancy. Although the safety of this strategy has been confirmed, the immunogenicity of Tdap vaccination in...
7.
Embacher S, Maertens K, Herzog S
J Infect Dis
. 2023 Jun;
228(11):1640-1648.
PMID: 37285482
Background: To reduce the risk of pertussis-related morbidity and mortality in early life, an increasing number of countries recommend maternal pertussis vaccination. However, there is limited knowledge about half-lives of...
8.
Ekinci E, Willen L, Rodriguez Ruiz J, Maertens K, van Heirstraeten L, Serrano G, et al.
Front Microbiol
. 2023 May;
14:1160073.
PMID: 37168112
Background: Non-typeable has become increasingly important as a causative agent of invasive diseases following vaccination against type b. The emergence of antibiotic resistance underscores the necessity to investigate typeable non-b...
9.
De Brabandere L, Hendrickx G, Poels K, Daelemans W, Van Damme P, Maertens K
BMJ Open
. 2023 Feb;
13(2):e066367.
PMID: 36764726
Background: Pregnant women, foetuses and infants are at risk of infectious disease-related complications. Maternal vaccination is a strategy developed to better protect pregnant women and their offspring against infectious disease-related...
10.
Abu-Raya B, Forsyth K, Halperin S, Maertens K, Jones C, Heininger U, et al.
Vaccines (Basel)
. 2022 Dec;
10(12).
PMID: 36560400
Infants are at high risk for severe morbidity and mortality from pertussis disease during early infancy. Vaccination against pertussis in pregnancy has emerged as the ideal strategy to protect infants...